Session » Vasculitis – ANCA-Associated Poster II
-
Abstract Number: 1661
Circulating Cell Free DNA Released from Eosinophils Is a Practical Biomarker in Patients with Eosinophilic Granulomatosis with Polyangiitis
-
Abstract Number: 1662
Does PR3-ANCA+ Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss)Really Exist?
-
Abstract Number: 1663
Assessments of Quality of Life in Patients with Eosinophilic Granulomatosis with Polyangiitis
-
Abstract Number: 1664
Reducing the Number of Rituximab Infusions at Onset of Maintenance Therapy for ANCA-associated Vasculitides: Results of a Post Hoc Analysis from a Randomized–controlled Trial
-
Abstract Number: 1666
Maintenance Treatment in ANCA Associated Vasculitis in Real World Clinical Practice – Burden of Disease, Use of Glucocorticoids and Impact on Patient Functional Status Remain Major Problems
-
Abstract Number: 1667
Long Term Outcome of Hydralazine-Associated Vasculitis
-
Abstract Number: 1668
Granulomatosis with Polyangiitis: Data from the French Vasculitis Study Group Registry
-
Abstract Number: 1669
Comparison of Mizoribine with Azathioprine in Efficacy and Safety for ANCA-Associated Vasculitis
-
Abstract Number: 1671
Hospital Admissions and Mortality in Patients with ANCA-associated Vasculitis
-
Abstract Number: 1672
Use of Rituximab for the Treatment of ANCA-Associated Vasculitis in Canada, 2010-2018
-
Abstract Number: 1673
Factors Associated with Overall and First-Year Mortality in Turkish Patients with ANCA-Associated Vasculitides: Retrospective, Multicentre Trial
-
Abstract Number: 1674
Survival in ANCA-Associated Vasculitis in a Latin-American Center: 28 Years of Experience
-
Abstract Number: 1675
A Retrospective Cohort Study Using Clinical Notes and Latent Topic Modeling to Characterize the Natural History of ANCA-Associated Vasculitis
-
Abstract Number: 1676
Does Pneumocystis Jiroveci Pneumonia (PJP) Prophylaxis Prevent Hospitalizations for Other Infections in Vasculitis Patients?
-
Abstract Number: 1677
Management of Severe Renal Disease in Anti-Neutrophil-Cytoplasmic-Antibodies Associated Vasculitis: Role of Rituximab and Plasma Exchange?
-
Abstract Number: 1678
Interstitial Lung Disease in ANCA Associated Vasculitis: A Single Center Retrospective Analysis
-
Abstract Number: 1681
The Association of Reduced Low-Density Lipoprotein (LDL) Cholesterol Levels with ANCA-Associated Vasculitis (AAV)
-
Abstract Number: 1682
Inpatient Epidemiology of Granulomatosis with Polyangiitis in the United States